We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Experimental Chikungunya Vaccine Induces Robust Antibody Response

News   Aug 16, 2014

 
Experimental Chikungunya Vaccine Induces Robust Antibody Response
 
 
 

RELATED ARTICLES

Chilled and Feisty Immune Cells Reside in the Gut

News

A new study has characterized distinct populations of immune cells that contribute to inflammatory bowel disease It is hoped that the findings will aid in developing treatments targeting inflammation while preserving healthy gut function.

READ MORE

Dangerous Brain Parasite "Orders In" for Dinner

News

Toxoplasma gondii, a single-celled parasite, can invade virtually all types of cells in the body. The parasite extracts most of the nutrients it needs for replication from its host cell, including essential amino acids like arginine.

READ MORE

Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial

News

An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE